Tag Archive for: Wheeler Bio

Life Science Partner announces the recruitment of Stewart McNaull, PhD, to develop commercialization and expand access of Wheeler Bio’s products and service offerings.

Stewart McNaull

Wheeler Bio, a quickly growing CDMO, retained Life Science Partner to recruit their President and Chief Operating Officer in 2022 to accelerate their advancement as an industry leader in biologics development services. After a thorough search, the company hired a seasoned executive to lead their strategic business opportunities and joint ventures. Early in 2023, Wheeler Bio contacted Life Science Partner to repeat the search to better fulfill the needs of the company.

As a result of reconvening the search and in partnership with the Wheeler Bio Board, Life Science Partner recruited Stewart McNaull, PhD, former Vice President and Business Unit Head, Biologics and Vaccines for Resilience, to serve as Wheeler’s Senior Vice President, Chief Business Officer.

With his extensive commercial experience in the CDMO industry, McNaull will have a tremendous impact on the establishment of Wheeler’s strategic alliances and sales channel development.”

Tom Callaway, MD, Founder of Life Science Partner.

While at Resilience, McNaull managed the business operations and strategy for the Biologics and Vaccines commercial franchise encompassing seven development and manufacturing sites worldwide. Leading the design and execution of the company’s network development and sales/marketing strategy, McNaull was successful in spear-heading rapid growth and expansion of the company’s Biologics and Vaccines business.

Prior to his role at Resilience, McNaull served as Senior Vice President, Business Development for KBI Biopharma where he had global responsibility for the company’s sales and marketing strategy. Earlier in his career, McNaull served in business development and scientific engineering leadership roles for Diosynth Biotechnologies and Bayer Biologics.

McNaull received his Bachelor of Science degree in Chemical Engineering from North Carolina State University and his PhD in Chemical Engineering from the Georgia Institute of Technology.

Life Science Partner shares an inside conversation of their recruitment partnership with advanced biologics CDMO, Wheeler Bio.

In the fall of 2022, Jesse McCool, PhD, Founder and CEO and the Board of Directors of Wheeler Bio retained Life Science Partner to recruit their new President and Chief Operating Officer.  In partnership with Dr. McCool, Life Science Partner identified, qualified, and recruited Roger Lias, PhD, an industry veteran who was most recently Chief Operating Officer of Vibalogics.

Tom Callaway, MD, Founder of Life Science Partner, sat down with McCool and Lias to discuss Wheeler’s advancements in the Contract Development and Manufacturing Operation (CDMO) market and converse on the two sides of the candidate/client recruitment process.

Wheeler Bio continues their close relationship with Life Science Partner, having additionally recruited their Chief Development Officer, Brian Berquist, PhD, to accelerate their platform and emerge as a technological leader within the CDMO space.

Contact Life Science Partner to build out your transformational leadership team.

Life Science Partner announces the newest recruit for emerging CDMO:

Wheeler Bio, a CDMO, retained Life Science Partner to recruit their Chief Development Officer to lead their process development team and accelerate their platform as a technological leader within the CDMO space. Beginning in January 2023, Brian Berquist, PhD, will lead the team in Wheeler Bio’s newstate-of-the-art Oklahoma City facility, where they have revolutionized the speed of drug discovery and democratized the innovation-to-impact process.

Brian Berquist

Berquist’s solid scientific background and ability to problem-solve in an entrepreneurial environment makes him well-suited for the R&D and innovation advancements he will undertake at Wheeler Bio.

Tom Callaway, MD, Founder of Life Science Partner

In his new role as Chief Development Officer, Berquist will oversee operations including cell line development, cell culture process development, purification development, analytical development, and formulation development. He will serve as Wheeler Bio’s scientific subject-matter expert and will lead his team in the continuous improvement of advancing the company’s R&D and technology platforms.

Prior to joining Wheeler Bio, Berquist served as the Vice President of Process Development and Analytical Sciences for iBio CDMO where he directed the process development and analytical sciences divisions for both development and characterization of proprietary products and services. Earlier in his career, Berquist served in key scientific and research roles for Caliber Biotherapeutics and Texas A&M Health Science Center.

Berquist holds a Bachelor of Science degree in Biochemistry and Molecular Biology from the University of Massachusetts, and he earned his PhD in Molecular Medicine and Molecular and Cellular Biology from the University of Maryland.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner announces the recruitment of Roger Lias, PhD, to Wheeler Bio to advance their expansion as cutting-edge biologics CDMO.

Roger Lias Wheeler Bio

Wheeler Bio, a CDMO, retained Life Science Partner to recruit their President and Chief Operating Officer to accelerate their growth as an industry leader in biologics development services. With a new state-of-the-art Oklahoma City facility, Wheeler Bio has revolutionized the speed of drug discovery with their novel hub-and-spoke concept and Portable CMC® platform that fast-tracks the pathway to IND.

After a nationwide search campaign, Roger Lias, PhD, former Chief Commercial Officer of Vibalogics, was recruited by Life Science Partner to serve as Wheeler Bio’s President and Chief Operating Officer beginning in September 2022.

Lias’ well-established credibility in the biopharma CDMO industry combined with his entrepreneurial leadership experience made him an absolute fit for growing Wheeler Bio into the global partner of choice for biological companies.”

Tom Callaway, MD, Founder of Life Science Partner

Lias will hit the ground running joining the Wheeler Bio team at the BioProcess International Conference in Boston this month, September 2022. In his new role Lias will be responsible for spearheading strategic business opportunities, alliances and joint ventures and will lead a scalable business operations team keeping Wheeler’s technology development and functions aligned with the corporate strategy as industry demand increases.

Prior to joining Wheeler Bio, Lias served as the Chief Commercial Officer for Vibalogics, a Private Equity-backed CDMO that was acquired by Recipharm AB in February, 2022.  He has an extensive track record of entrepreneurial successes including Stelis Biopharma, Avid Biosciences, Allergan, Eden Pharma, Cytovance and KBI Biopharma.

Lias holds a Bachelor of Science degree in Physiology and Biochemistry from the University of Southampton in the United Kingdom. He earned his PhD from Clare College, University Cambridge.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.